DOI (Am J Clin Nutr): https://doi.org/10.1016/j.ajcnut.2023.11.018
What the study examined
Iron fortification is one of the most widely deployed public-health interventions against infant anemia, yet a growing body of evidence shows that the large fraction of oral iron that escapes absorption travels to the colon, where it can shift the microbiome toward Enterobacteriaceae and enteropathogens, raise intestinal inflammation, and increase diarrhea. This trade-off is especially acute in sub-Saharan Africa, where baseline enteropathogen burden is high. Mikulic and colleagues (Am J Clin Nutr, 2024), working within the Zimmermann and Paganini research program at ETH Zurich, tested whether co-delivering a prebiotic could preserve the anti-anemia benefit of iron while neutralizing its collateral damage to the gut.
The team enrolled 191 infants aged 6-11 months in Kwale County, Kenya, a population in which 74.6% were anemic and 79.4% were iron deficient at baseline. Infants consumed a wheat-based instant cereal daily for three weeks in one of three arms: iron alone (ferrous fumarate plus ascorbic acid), iron plus 3 g GOS/FOS, or iron plus 7.5 g GOS/FOS (a 9:1 GOS-to-FOS ratio). A 66-infant substudy used dual stable iron isotopes (57Fe and 58Fe) with erythrocyte incorporation to quantify fractional iron absorption from labeled test meals eaten with and without prebiotics, both before and after the intervention. Gut outcomes were assessed with qPCR, 16S rRNA sequencing, and shotgun metagenomics, alongside fecal pH and fecal calprotectin as a marker of intestinal inflammation.
The key findings
Prebiotics measurably improved iron uptake. Adding GOS/FOS to a test meal raised fractional iron absorption by about 26% acutely at baseline (from roughly 16.3% to 20.5%). After three weeks of daily prebiotic-plus-iron cereal, absorption from a prebiotic test meal reached about 26.0%, a ~60% increase over the baseline no-prebiotic value, indicating both an acute solubilizing effect and a longer conditioning effect on the gut. There was no meaningful difference between the 3 g and 7.5 g doses on absorption.
On the microbiome side, the prebiotic arms showed higher abundances of Lactobacillus/Pediococcus/Leuconostoc, while the 7.5 g arm showed significantly lower Enterobacteriaceae and a lower summed abundance of targeted pathogens (Campylobacter, Salmonella, Clostridium difficile, C. perfringens, and enteropathogenic and enterotoxigenic E. coli) relative to the iron-only group. Bacterial toxin-encoding genes were reduced in the 3 g arm. Fecal pH fell to about 5.0 in the 7.5 g arm versus 5.5 with iron alone, and fecal calprotectin was lower in the 7.5 g arm (about 198 vs 361 micrograms/g), consistent with reduced neutrophilic gut inflammation. Systemic C-reactive protein was also lower in a prebiotic arm.
The mechanism: luminal iron, competition, and fermentation
Oral iron is absorbed only partially in the proximal small intestine; the unabsorbed remainder becomes a luminal resource in the colon. Because iron is a growth-limiting nutrient for many enteric bacteria, an influx of poorly absorbed iron can favor siderophore-competent Enterobacteriaceae and pathogens over beneficial Bifidobacterium and Lactobacillus, tilting microbial competition toward organisms associated with inflammation and diarrhea. This is the adverse pathway that iron fortification alone can trigger.
GOS and FOS intervene at two points. First, they are selectively fermented by beneficial saccharolytic bacteria into short-chain fatty acids, which acidify the lumen (reflected in the drop in fecal pH). A lower pH suppresses acid-sensitive Enterobacteriaceae and enteropathogens while favoring lactobacilli, and it also improves iron solubility and mucosal uptake, which helps explain the higher fractional absorption. Second, by promoting beneficial competitors and enhancing host absorption, prebiotics reduce the pool of free iron available to pathogens in the distal gut. The net effect is more iron reaching the infant and less iron feeding a pathogenic bloom.
How it fits the metal-microbiome-disease axis
Iron is an essential nutrient rather than a toxic heavy metal, so this study is not a case of environmental contaminant exposure. But it is a clean, mechanistically detailed illustration of the same causal logic that runs through the metal-microbiome-disease axis: the availability of a metal in the gut lumen reshapes microbial community structure, and that reshaping drives host inflammation and infection risk. Here the readout is direct, with unabsorbed luminal iron increasing enteropathogen abundance, toxin-gene load, and calprotectin-marked inflammation, all of which are downstream steps on the path from metal exposure to disease.
The study is also instructive because it demonstrates the axis in reverse: a targeted intervention that changes the luminal chemistry (prebiotic fermentation and acidification) interrupts the metal-driven dysbiosis and dampens inflammation. Notably, fecal calprotectin, the inflammation marker used here, is itself a nutritional-immunity protein that host neutrophils deploy to sequester manganese and zinc from microbes, so the same host machinery that governs metal availability is central to reading out the effect. The broader lesson for the axis is that the form, dose, and co-delivery of a metal, not merely its presence, decide whether it perturbs the microbiome toward disease.
Supporting evidence and context
This trial extends an earlier controlled study from the same group, Paganini et al. (Gut, 2017; 66:1956-1967), which showed that adding 7.5 g GOS to an iron-containing micronutrient powder mitigated the adverse microbiome shifts, virulence-gene increases, and gut-damage markers caused by iron alone in Kenyan infants while preserving a roughly 50% reduction in anemia. Together the two studies triangulate a consistent conclusion across different iron vehicles (micronutrient powder and fortified cereal): co-delivered prebiotics decouple iron's hematologic benefit from its microbiome cost.
Important caveats remain. The intervention lasted only three weeks, home consumption was not directly supervised, and fractional iron absorption was measured only in the prebiotic arms rather than against the iron-only control. Longer trials with clinical endpoints such as diarrhea and infection incidence are needed to confirm that the favorable microbiome and inflammation signals translate into reduced disease. The findings should be read as strong mechanistic and biomarker evidence, not yet as proof of long-term clinical protection.
Key findings
- Adding prebiotic GOS/FOS to iron-fortified cereal raised fractional iron absorption by about 60% over baseline in Kenyan infants, with no significant difference between the 3 g and 7.5 g doses.
- The 7.5 g prebiotic arm showed lower Enterobacteriaceae and a lower summed abundance of enteropathogens (Campylobacter, Salmonella, C. difficile, C. perfringens, EPEC, ETEC) versus iron alone.
- Prebiotic arms had higher Lactobacillus-group abundance and lower fecal pH (about 5.0 vs 5.5), consistent with short-chain-fatty-acid fermentation and pathogen suppression.
- Fecal calprotectin, a marker of neutrophilic gut inflammation, was lower with 7.5 g prebiotic (about 198 vs 361 micrograms/g), and one prebiotic arm also had lower systemic C-reactive protein.
- Unabsorbed luminal iron drives the adverse effects; prebiotics work by feeding beneficial competitors, acidifying the gut, and improving host iron uptake, leaving less free iron for pathogens.
- Results replicate and extend Paganini et al. (Gut, 2017), which found GOS mitigated iron's microbiome harms when iron was delivered via micronutrient powder.
Frequently asked questions
Does iron fortification harm the infant gut microbiome?
It can. Poorly absorbed oral iron reaches the colon, where it favors Enterobacteriaceae and enteropathogens over beneficial Bifidobacterium and Lactobacillus, raising intestinal inflammation and diarrhea risk, especially in high-pathogen settings. This trial and the related Paganini 2017 Gut study both document that adverse shift when iron is given alone.
How do prebiotics like GOS increase iron absorption?
Beneficial gut bacteria ferment GOS and FOS into short-chain fatty acids that lower luminal pH. The more acidic environment increases iron solubility and mucosal uptake and suppresses acid-sensitive pathogens. In this RCT, prebiotics raised fractional iron absorption by roughly 60% over baseline while also reducing enteropathogens.
Did the prebiotic dose matter?
For iron absorption, no: the 3 g and 7.5 g GOS/FOS doses produced similar increases. For microbiome and inflammation outcomes, the higher 7.5 g dose showed the clearest benefits, including lower Enterobacteriaceae, lower summed pathogen abundance, lower fecal pH, and lower fecal calprotectin.
What does this study add to the metal-microbiome-disease picture?
It shows mechanistically that a metal's luminal availability, not just its dose, shapes microbial competition and host inflammation. Unabsorbed iron feeds pathogens and inflames the gut, while a prebiotic that changes gut chemistry interrupts that pathway. It is a nutrient-metal illustration of the same exposure-to-microbiome-to-disease logic seen with toxic metals.